A

ALIM

Alimera Sciences

This stock has been delisted.
News
Press Releases
Financial Reports
Profile
    Same Industry
    Name/Symbol
    Change%
    Price

    ALIM

    --

    麥克森

    MCK

    -1.92%
    742.44

    生物基因

    BIIB

    -0.20%
    196.00

    安進

    AMGN

    +0.09%
    336.79

    沙爾製藥

    SHPG

    0.00%
    179.20

    B

    Bristol-Myers Squibb Company Celegne Contingent Value Rights

    CELG-RT

    +0.26%
    0.1153

    禮來

    LLY

    -1.93%
    --

    新基醫藥

    CELG

    0.00%
    108.24

    T

    Therapeuticsmd Inc

    TXMD

    +1.42%
    2.140

    強生

    JNJ

    -2.37%
    225.33

    艾伯維

    ABBV

    -2.20%
    212.93

    Z

    Zoetis Inc

    ZTS

    -0.17%
    77.56

    吉利德科學

    GILD

    -1.31%
    134.43

    N

    Novo-Nordisk A/S

    NVO

    +0.15%
    45.58

    百時美施貴寶

    BMY

    +0.47%
    57.18

    輝瑞製藥

    PFE

    +0.15%
    26.18

    亞力兄製藥

    ALXN

    +1.70%
    182.50

    賽諾菲

    SNY

    -1.40%
    43.67

    S

    Sanofi FR

    GCVRZ

    0.00%
    0.8711

    諾華製藥

    NVS

    -0.81%
    150.17

    D

    Dr Reddys Labs

    RDY

    +0.81%
    13.63

    Contact Us

    Contact Number :+852 3852 8500
    Monday 7:00 AM - Saturday 9:00 AM (HKT)
    Service Email :service@webull.hk
    Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
    Business Cooperation :marketinghk@webull.hk
    Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
    Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
    Language

    English

    ©2026 Webull Securities Limited. All rights reserved.